Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis-Reference-Cited by-同舟云学术

Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis

Published:2020-08 Issue:4 Volume:155 Page:152-158
ISSN:2387-0206
Container-title:Medicina Clínica (English Edition)
language:en
Short-container-title:Medicina Clínica (English Edition)

Author:

Pastor-Galán Irene,Hernández-Boluda Juan Carlos,Correa Juan-Gonzalo,Alvarez-Larrán Alberto,Ferrer-Marín Francisca,Raya José María,Ayala Rosa,Velez Patricia,Pérez-Encinas Manuel,Estrada Natalia,García-Gutiérrez Valentín,Fox María Laura,Payer Angel,Kerguelen Ana,Cuevas Beatriz,Durán María Antonia,Ramírez María José,Gómez-Casares María Teresa,Mata-Vázquez María Isabel,Mora Elvira,Martínez-Valverde Clara,Arbelo Elisa,Angona Anna,Magro Elena,Antelo María Luisa,Somolinos Nieves,Cervantes Francisco

Funder

Novartis

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Pathogenesis of myelofibrosis with myeloid metaplasia;Tefferi;J Clin Oncol,2005

2. How common are myeloproliferative neoplasms? A systematic review and meta-analysis;Timarsh;Am J Hematol,2014

3. Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms;Grinfeld;Haematologica,2017

4. Mutations and prognosis in primary myelofibrosis;Vannucchi;Leukemia,2013

5. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis;Tefferi;Blood,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives;Frontiers in Oncology;2024-07-24

2. Carga socioeconómica de la mielofibrosis en pacientes con y sin anemia en España;Economía de la Salud;2023-12

3. JAK Be Nimble: Reviewing the Development of JAK Inhibitors and JAK Inhibitor Combinations for Special Populations of Patients with Myelofibrosis;Journal of Immunotherapy and Precision Oncology;2021-06-22